| Final Research Plan: Medication Use for the Risk Reduction of Primary Breast Cancer in Women |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Ovarian Cancer |
|
| Public Comment on Draft Research Plan: Screening for Hepatitis B Virus Infection in Pregnant Women |
|
| Final Recommendation Statement: Screening for Obesity in Children and Adolescents |
|
| Three Final Research Plans: HIV Screening and Prevention |
|
| Public Comment on Draft Research Plan: Screening for Syphilis Infection in Pregnant Women |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Adolescent Idiopathic Scoliosis |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions |
|
| Final Recommendation Statement: Screening for Thyroid Cancer |
|
| Public Comment on Draft Research Plan: Screening for Pancreatic Cancer |
|
| Final Recommendation Statement: Screening for Preeclampsia |
|
| AHRQ Seeks Nomination of New Members to the U.S. Preventive Services Task Force |
|
| Public Comment on Draft Recommendation Statement: Screening for Prostate Cancer |
|
| Final Recommendation Statement: Screening for Celiac Disease |
|
| Public Comment on Draft Research Plan: Medication Use for the Risk Reduction of Primary Breast Cancer in Women |
|
| Public Comment on Draft Research Plan: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA Related Cancer |
|
| Final Recommendation Statement: Screening for Gynecologic Conditions With Pelvic Examination |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Vision Screening in Children Ages 6 Months to 5 Years |
|
| Public Comment on Three Draft Research Plans: HIV Screening and Prevention |
|
| Final Recommendation Statement: Screening for Obstructive Sleep Apnea in Adults |
|
